Bridgepoint acquires CABB

Private equity firm Bridgepoint has bought German-based supplier of chlorine-based chemicals, CABB.

The deal, for an undisclosed amount, achieves an exit for AXA Private Equity, which acquired CABB in 2006.

CABB currently operates from four manufacturing sites in Germany, Switzerland and India and has offices in the UK. Bridgepoint is targeting greater growth for CABB though ‘targeted bolt-on acquisitions’, according to a statement released by the company.

Uwe Kolb, Bridgepoint partner for investment in Germany comments: ‘CABB fits the Bridgepoint investment criteria well. The company has a leading position in its markets, a solid cash flow as well as potential to realise further growth by means of a globalisation strategy.’

The acquisition comes one week after Bridgepoint bought French private hospital group, Medipole Sud Sante.

Todd Cardy

Todd Cardy

Todd was Editor of between 2010 and 2011 as well as being responsible for publishing our digital and printed magazines focusing on private equity and venture capital.

Related Topics